Therapy related acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS) have

Therapy related acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS) have already been classically associated with alkylating providers and topoisomerase inhibitors. timeline of occasions in our individual, paclitaxel may be the most likely culprit in the pathogenesis of the myeloid neoplasm. This uncommon but considerably grave adverse impact should be held in thought when choosing… Continue reading Therapy related acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS) have